In this cross-sectional investigation, we evaluated circulating LBP in relation to obesity, NAFLD, visceral adipose tissue (VAT) inflammation, and type 2 diabetes (T2D). This evidence concerns the gene LBP and metabolic dysfunction-associated steatotic liver disease.